Profile for European Patent Office Patent: 2950648
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2950648
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,278,918 | Jan 31, 2034 | Famygen Life Sci | RYZUMVI | phentolamine mesylate |
| 10,772,829 | Jan 31, 2034 | Famygen Life Sci | RYZUMVI | phentolamine mesylate |
| 11,090,261 | Jan 31, 2034 | Famygen Life Sci | RYZUMVI | phentolamine mesylate |
| 11,844,858 | Jan 31, 2034 | Famygen Life Sci | RYZUMVI | phentolamine mesylate |
| 12,350,366 | Jan 31, 2034 | Famygen Life Sci | RYZUMVI | phentolamine mesylate |
| 12,721,810 | Jan 31, 2034 | Famygen Life Sci | RYZUMVI | phentolamine mesylate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
